bioMérieux – Verniolle – Le laboratoire français bioMérieux, acteur majeur dans le diagnostic des maladies infectieuses, a mobilisé ses experts début mars 2020, pour mettre au point de nouveaux tests sérologiques. Forte de 30 ans d’expérience et d’experts engagés, il aura fallu seulement six semaines à l’équipe R&D de bioMérieux pour mettre au point des tests sérologiques fiables. Les tests VIDAS-SARS-COV-2-IgG et VIDAS-SARS-COV-2 IgM sont aujourd’hui marqués CE-IVD pour compléter ou confirmer le diagnostic de COVID-19.
https://diag-innov.biomerieux.fr/tests-serologiques-vidas-sars-cov-2-diagnostic-covid-19/
C4Diagnostics – Marseille – C4Diagnostics develops innovative tests to diagnose viruses and bacteria responsible for infectious diseases in humans. Its rapid and sensitive in vitro diagnostic tests make it possible to respond to public health challenges such as the management of epidemics. C4Diagnostics responded to the pandemic by developing a range of diagnostic solutions to detect the coronavirus on surfaces, in the air and wastewater. A saliva screening test in humans is also in clinical trials for CE marking planned for the end of 2020.
“In 2020, we committed to the fight against Covid-19 alongside the Bataillondes Marins-Pompiers de Marseille by analyzing more than 10,000 samples in our P2 laboratory. We also support companies in different industrial sectors to secure their premises and protect their staff by implementing Covid-19 monitoring systems adapted to each site. The entire team was fully mobilized to develop in record time a range of diagnostic solutions to detect the coronavirus in the environment and in humans, thus making our contribution to the management of this pandemic,” Younes Lazrak, President of C4Diagnostics
Genochem - Grasse- The company Genochem has worked on an innovative method to test in less than an hour, through an automated process, the presence of viral particles from all types of samples.
https://ecomnews.fr/article/Grasse-3-entreprises-sciences-vivant-sante-mobilisent-lutter-covid-19
ID-Solutions – Grabels- The company ID-Solutions has developed a ready-to-use RT-qPCR detection kit to specifically amplify the viral RNAs of SARS-CoV-2 and Influenza A/B after extraction from patient samples . This test makes it possible to differentiate seasonal flu from SARS-CoV-2 infection.
http://www.id-solutions.fr/fr/kits-de-detection/idtm-sars-cov-2-influenza/
IDvet – Grabels – The company IDvet has launched the marketing of a serological test to detect antibodies against COVID-19 with a specificity of 99.9%. It makes it possible to very significantly reduce the rate of false positives.
https://www.id-vet.com/wp-content/uploads/IDVET_COMMUNIQUE-DE-PRESSE_7-MAI-2020.pdf
Intrasense – Montpellier- The company Intrasense, specialist in medical imaging software solutions and designer of the Myrian® integrated digital platform, has obtained CE marking for its new COVID-19 scanner protocol, a world first. This step allows a real mass deployment of the solution both in Europe thanks to this CE marking but also in the United States, with FDA authorization. Usable at all key stages of the fight against the epidemic, from screening to clinical monitoring including analysis of the pathological stage, the protocol allows objective and precise quantification of the patient's lung damage, thus optimizing adaptation of the therapeutic response.
https://www.intrasense.fr/wp-content/uploads/2020/04/CP_Intrasense_marquage-CE-Covid.pdf
SeqOne – Montpellier – The SeqOne company is joining forces with industrial leaders to contribute to the massive increase in national screening capacity. The company has fully mobilized on this front and offers a new solution that exploits the capabilities of the latest generation of very high throughput genomic analysis devices.
Sys2Diag, SkillCell, Vogo – Montpellier – Faced with the Covid19 health crisis, the consortium bringing together the Sys2Diag laboratory, the Montpellier University Hospital, the biotechnology company SkillCell and the company Vogo has developed EasyCov, a saliva test for detecting Covid-19, with a colorimetric reading of the results, all in 40 minutes. The device obtained CE marking in June, and is already marketed in Europe and around the world.
The High Authority of Health has validated the use of the EasyCoV saliva test for the Covid diagnosis of symptomatic people who cannot undergo a nasopharyngeal swab.